Does a Series B biotech company need a fractional CRO in 2027?

Direct Answer

For a Series B biotech in 2027, the question isn't whether you *need* a fractional CRO — it's whether your current revenue engine is scaling predictably or hitting a ceiling. Biotech sales cycles are long, involve multiple stakeholders (scientific, clinical, procurement), and demand deep domain credibility. A fractional CRO brings that credibility and process rigor without the multi-year commitment or full-time compensation package. If your CEO is still closing the largest deals personally, and your sales team lacks a structured revenue playbook, a fractional CRO is likely a smart, cost-effective bridge to the next stage.

The Biotech Revenue Reality in 2027

Biotech companies at Series B are often in a difficult position. You've raised enough capital to survive 18–24 months, you have promising clinical data or a platform technology, and you're generating some early revenue — but the sales cycle is long, complex, and unpredictable. Your buyers include CSOs, VPs of R&D, procurement managers, and sometimes regulatory affairs. Each deal can take 6–18 months from first conversation to signed contract.

In this environment, a traditional full-time CRO hire can feel like a gamble. You're betting that the person can learn your science, build a team, and close enough deals before your runway runs out. If they don't work out, you've burned months and hundreds of thousands of dollars. A fractional CRO, by contrast, is a lower-risk way to test whether you need that level of leadership at all.

What a Fractional CRO Actually Does for a Biotech

A good fractional CRO doesn't just "advise" — they operate. They'll typically spend 2–3 days per week on your business, focused on:

• Designing your revenue process: Defining your ideal customer profile (ICP), building a sales playbook, and setting up a repeatable qualification framework (e.g., BANT or MEDDIC adapted for biotech).
• Coaching your sales team: If you have a VP of Sales or Director of Sales, the fractional CRO works through them — not around them. They provide strategic direction, deal reviews, and accountability.
• Closing strategic deals: The fractional CRO often takes the lead on your top 3–5 enterprise opportunities, especially those requiring C-level conversations.
• Building your revenue stack: They'll recommend and help implement tools like Salesforce, HubSpot, Gong, or Clari — but only what's actually needed, not a full suite from day one.
• Hiring and structuring: They can help you define roles, write job descriptions, and interview candidates for your next sales hires.

The key difference from a consultant is that a fractional CRO owns outcomes. They're accountable for revenue targets, not just delivering a deck.

When a Fractional CRO Is the Wrong Choice

Honesty requires acknowledging the downsides. A fractional CRO is not the right solution if:

• You have no sales leadership at all. If your CEO is the only person selling and there's no VP or Director of Sales to execute day-to-day, a fractional CRO may be too hands-off. You likely need a full-time VP of Sales first.
• Your revenue model is still unproven. If you haven't closed a single paying customer yet, a fractional CRO is premature. You need founder-led sales and product-market fit validation, not executive oversight.
• You need full-time cultural leadership. A fractional CRO can't be at every all-hands, every team meeting, or every customer call. If your team needs a constant revenue leader in the room, go full-time.
• Your budget is extremely tight. Even at $8k/month, a fractional CRO is a real expense. If you're burning through cash and every dollar counts toward R&D, delay the hire.

How to Hire a Fractional CRO for a Biotech

The market for fractional CROs has matured significantly by 2027. You can find candidates through networks like Pavilion, RevOps Co-op, or directly through firms like CRO Syndicate. When evaluating candidates, prioritize:

• Domain experience: Have they sold into biotech, pharma, or life sciences before? The learning curve for your science is steep. A fractional CRO who understands the buyer's journey in regulated environments is worth more than one with general SaaS experience.
• References from similar stages: Ask for references from other Series A or B companies, ideally in biotech or deep tech. What did they actually deliver?
• Process orientation: Ask them to walk through how they'd design your sales process in the first 90 days. If they can't articulate a clear, measurable plan, keep looking.
• Availability and responsiveness: A fractional CRO who is overcommitted (working with 5+ clients) won't be available when you need them. Clarify expected hours per week and response times.

The Cost Question: What You'll Really Pay

Fractional CRO compensation varies widely. Here are the honest drivers:

• Scope: A pure strategic advisor (1–2 days/month) might cost $5k–$8k/month. A hands-on operator (3–4 days/week) can run $15k–$25k/month.
• Days per month: Most fractional CROs charge by the day or retainer. Expect $1,500–$3,000 per day for a seasoned executive.
• Stage: Series B biotechs with complex sales cycles command higher rates because the work is harder and more time-intensive.
• Equity: Some fractional CROs will accept a lower cash retainer in exchange for equity (typically 0.5%–2% vested over 2–3 years). This aligns incentives but dilutes founders.

A full-time CRO at a Series B biotech in 2027 would cost roughly $250,000–$350,000 base salary plus bonus and benefits, plus significant equity. The fractional route saves you 40–60% on cash compensation while giving you flexibility.

FAQ

What's the difference between a fractional CRO and a sales consultant? A fractional CRO owns revenue outcomes and typically works 2–3 days per week embedded in your team. A consultant delivers a report or recommendation and leaves. The fractional CRO is accountable for hitting targets.

How long should I keep a fractional CRO? Most engagements run 6–12 months. Some companies extend to 18 months if they're not ready for a full-time hire. The goal is to build a repeatable revenue engine that can eventually run with a full-time VP of Sales or CRO.

Can a fractional CRO work remotely for a biotech outside Boston/SF? Yes, but expect to invest in travel. A good fractional CRO will visit your site once a month and be available on video daily. If your company is in a smaller biotech hub (e.g., Research Triangle Park, Seattle), you may need to search nationally.

Will a fractional CRO replace my VP of Sales? No — they should complement and coach your existing sales leadership. If you have no VP of Sales, a fractional CRO can act as an interim leader while you hire one.

How do I measure success? Define clear metrics upfront: pipeline velocity, win rate, average deal size, and time to close. A fractional CRO should move these numbers within 90 days. If they don't, reassess.

What if I need to fire them? Most contracts have a 30-day termination clause. That's the advantage of fractional — you can exit quickly without the legal and cultural pain of firing a full-time executive.

Sources

• Pavilion – Community for revenue leaders
• RevOps Co-op – Revenue operations community
• Harvard Business Review – Sales leadership articles
• First Round Review – Startup sales and leadership
• SaaStr – SaaS and revenue scaling insights
• LinkedIn – Professional network for candidate sourcing

People also search for: fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost